Supporting the exciting and ever evolving life sciences sector, offering a full service offering from our team of experts, applying their deep sector knowledge at every stage of your journey.

 

The UK Life Sciences sector is at the forefront of innovation, driving healthcare advancements that solidify the UK’s global reputation as a leader in healthcare technology. It attracts thousands of highly skilled professionals and contributes significant improvements in patient outcomes.

 

However, businesses in this dynamic sector face unique challenges—from navigating complex regulatory requirements and safeguarding intellectual property, to securing funding and optimising tax relief opportunities.

 

Our specialised focus on ambitious businesses gives us unrivalled expertise and insights into the hurdles that growing and entrepreneurial businesses in life sciences encounter. Our specialist team, based in Oxford and London, are here to help you overcome these challenges and accelerate your success in this vital industry.

 

Who we work with

 

Gravita’s Life Sciences team brings a wealth of expertise, offering tailored advice to a wide range of businesses across the life sciences, biotech, and pharmaceutical industries. Our experience spans diverse activities, including:

 

  • Research intensive activities, often receiving significant R&D tax credits or grants
  • Early commercialisation of breakthrough technologies, formulations and devices
  • Commercial exploitation of established patents
  • Distribution of medical products and technologies
  • Performing clinical trials, diagnostic tests and other support services to industry leaders
  • Implementing AI-driven solutions in analysis or medical service delivery

 

 

Services we provide to the sector

 

We provide a comprehensive range of services tailored to the life sciences sector, including:

 

  • Specialist audit of financial statements
  • Tailored assurance engagements, including grant audits
  • Outsourced financial management, including bookkeeping, management accounts, digital records and VAT compliance
  • R&D Tax Credit advisory and compliance support
  • Preparation of statutory accounts under FRS 102, FRS 101 and IFRS including groups
  • Specialist accounting advisory including guidance on internally generated intangible assets, acquisitions and disposals, revenue recognition and share options
  • Tax compliance advisory on Patent Box, exit planning and international expansion issues
  • Transfer pricing support for international groups
  • Efficient remuneration strategies including employees share incentive schemes

 

 

Ready to elevate your life science business?

 

Get in touch today, and one of our experts will schedule a personalised consultation to kick-start your journey with us, or contact Gravita’s Life Sciences Lead Partner, Joseph Brewer.

Our clients within this sector

Our clients range from start-ups and university spin-offs up to international AIM-listed groups.  We are proud to be recognized as a Top 10 Auditor for AIM-listed companies by Adviser Rankings, with a strong presence in the life sciences sector.

Latest Insights

What the 2025 Autumn Budget could mean for Income tax and National Insurance

7th November 2025
Written by: Michaela Lamb
After Rachel Reeves’ speech on 4th November, it will come as no surprise that, we understand, she has spoken to the Office for Budget Responsibility (OBR) about increasing income tax by 2%, potentially to be...
link to Find Out More

Why now could be the moment to review your asset plans before the 2025 Autumn Budget

6th November 2025
Written by: Ian MacGillivray
As usual, the Press and media organisations have been busy speculating about what will be in the Budget which the Chancellor Rachel Reeves will deliver on 26th November 2025. Talk to us This has led...
link to Find Out More

What to do if you receive an HMRC letter about crypto tax

5th November 2025
Written by: Dion Laycock
HMRC has started contacting individuals it believes may have under-reported income or gains from crypto transactions. These “one to many” letters, often known as nudge letters, are being sent to taxpayers whose records suggest they...
link to Find Out More